REPORT SCOPE
INTRODUCTION
STUDY OBJECTIVES
BCC Research’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for liver disease drugs, including the market for end users. The key objective is to present a comprehensive analysis of the current liver disease drug market and its future direction by utilizing new methods for preventing globally widespread disease.
This report explores present and future strategies within the liver disease drug market, including market sizes, market leaders, market overview, and various other market factors, as well as the market for end users. The current state of the market, its setbacks, its innovations, and its future needs are also discussed.
A detailed analysis of the liver disease drug market and the industry structure has been conducted. This includes the different categories of liver disease drugs and the various types of liver disease broken down by market share belonging to leading manufacturers and/or suppliers. Revenues for each drug category and disease type are broken down by region. Sales figures are estimated for the 5-year period from 2011 through 2016.
The strategies and the prospects of the current market are also discussed. Companies that manufacture and sell new and innovative liver disease-related drugs are also profiled.
REASONS FOR DOING THIS STUDY
This study was conducted to provide detailed information regarding different liver disease drugs in response to an increasing need for new and innovative drug treatments. This industry is experiencing growth, as new product lines have been launched (e.g., Protease inhibitors for the treatment of hepatitis). The study looks at most of the different drug types and different liver diseases. It cites the research and development for almost all new drugs and applications. The changes in market behavior demonstrate the need to focus on this segment. Additionally, the study discusses the treatment options provided by these drugs to end users. Acquisitions, mergers, and alliances by companies and global organizations are also discussed.
INTENDED AUDIENCE
This study examines the areas of growth in the liver disease drug market from the point of view of both manufacturers and users. This study will be of interest largely to the pharmaceutical and biopharmaceutical industries, clinics, hospitals, and research institutes.
SCOPE OF THE STUDY
The scope of this study encompasses liver disease drug markets by various types. BCC Research analyzes each market by category with its applications in different regions of the world. It also analyzes the market leaders, regulatory environment, technology, market projections, and market share. Application issues include the latest trends and developments in each liver disease drug category.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with various trade experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain market data, including manufacturers, end users of drug delivery systems, members of the pharmaceutical and biotechnical industries, and research institutes. Data were gathered from various industry sources. BCC spoke with officials within the industry and also consulted newsletters, company literature, product literature, technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.
BCC ONLINE SERVICES
BCC Research offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine our complete catalog of Technology Market Research Reports, download tables of content, and order directly from BCC
- Access BCC’s online report database to download any amount of information, from individual records to entire chapters and reports
- Subscribe to any of our monthly technology and marketing newsletters
- Read announcements of upcoming reports and newsletters
- Register for BCC’s well-known conferences
- Request additional information regarding any BCC product
- Take advantage of special offers
ABOUT THE AUTHOR
This study has been carried out by a team of professionals in the biotechnology industry. The project manager is Shalini S. Dewan, who holds a Master’s degree in Pharmaceutical Chemistry and has more than 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest, including ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work, and she has worked with top companies in India and the U.S. Her other reports for BCC Research include Reagents for Chromatography; Spectroscopy, An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants, and Devices; Medical Imaging Reagents and Analysis Equipment ; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera, and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research, and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs, and Devices; and Cancer Therapies: Technologies and Global Markets.
DISCLAIMER
This publication provides informative material of a professional nature. It does not constitute managerial, legal, or accounting advice, nor should it serve as a corporate policy guide or an endorsement of any given product or company. This information is intended to be as accurate as possible at the time it was written and was undertaken on a best-effort basis. The views expressed are those of the author and do not make any warranty, express or implied, for the accuracy, completeness, or usefulness of the information, or for the interpretation of data or its use by others. Projections involve risks and uncertainties that include but are not limited to technical risks associated with technology development, government regulatory approvals, and access to capital. The author assumes no responsibility for any losses or damages that may result from one’s reliance on this material.
Source: BCC Research
